- Home
- INSP vs ACLX Comparison
INSP vs ACLX Comparison
Compare INSP & ACLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- INSP
- ACLX
- Stock Information
- Founded
- INSP 2007
- ACLX 2015
- Country
- INSP United States
- ACLX United States
- Employees
- INSP N/A
- ACLX N/A
- Industry
- INSP Medical/Dental Instruments
- ACLX Biotechnology: Pharmaceutical Preparations
- Sector
- INSP Health Care
- ACLX Health Care
- Exchange
- INSP Nasdaq
- ACLX Nasdaq
- Market Cap
- INSP 3.8B
- ACLX 4.4B
- IPO Year
- INSP 2018
- ACLX 2022
- Fundamental
- Price
- INSP $73.75
- ACLX $85.95
- Analyst Decision
- INSP Buy
- ACLX Strong Buy
- Analyst Count
- INSP 16
- ACLX 13
- Target Price
- INSP $147.07
- ACLX $114.38
- AVG Volume (30 Days)
- INSP 1.1M
- ACLX 465.8K
- Earning Date
- INSP 11-03-2025
- ACLX 11-07-2025
- Dividend Yield
- INSP N/A
- ACLX N/A
- EPS Growth
- INSP 756.73
- ACLX N/A
- EPS
- INSP 1.74
- ACLX N/A
- Revenue
- INSP $861,312,000.00
- ACLX $56,979,000.00
- Revenue This Year
- INSP $14.83
- ACLX N/A
- Revenue Next Year
- INSP $14.44
- ACLX $220.95
- P/E Ratio
- INSP $42.31
- ACLX N/A
- Revenue Growth
- INSP 22.05
- ACLX N/A
- 52 Week Low
- INSP $70.77
- ACLX $47.86
- 52 Week High
- INSP $216.01
- ACLX $107.37
- Technical
- Relative Strength Index (RSI)
- INSP 40.48
- ACLX 52.42
- Support Level
- INSP $75.64
- ACLX $84.85
- Resistance Level
- INSP $84.23
- ACLX $88.58
- Average True Range (ATR)
- INSP 2.90
- ACLX 3.85
- MACD
- INSP -0.39
- ACLX -0.34
- Stochastic Oscillator
- INSP 18.00
- ACLX 28.92
About INSP Inspire Medical Systems Inc.
Inspire Medical Systems Inc operates as a medical technology company. It focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA). It offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe obstructive sleep apnea. The firm has operating footprints in the United States and Europe wherein, it generates a majority of its revenue from the United States.
About ACLX Arcellx Inc.
Arcellx Inc a clinical-stage biotechnology company reimagining cell therapy through the development of immunotherapies for patients with cancer and other incurable diseases. Its pipeline includes Multiple Myeloma, Acute Myeloid Leukemia, Non-Oncology, and Solid Tumors.